Vanda Pharmaceuticals (VNDA) Reports In-Line Q1 EPS
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
